Evaluate the efficacy of riluzole 50-mg bid defined by comparing the percentage of
riluzole-treated subjects who experienced death, permanently assisted ventilation (PAV) or
tracheostomy, to a group of recent historical controls for the treatment of amyotrophic
lateral sclerosis (ALS).